Oxidation Systems

WHITE PAPERS AND CASE STUDIES

• Data Key In Addressing Patient Recruitment Challenges

  Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.

• End-To-End Inventory Control Supports Biotech's Expanding Portfolio

  Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.

• Flexible Integrations To Reduce Risks And Increase Efficiencies

  Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.

• No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure

  This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.

• Electronic Body Maps Drive Standardization Across Top-10 Pharma

  Learn how a top-10 pharmaceutical client was able to "fundamentally transform the way they execute clinical trials" with the digitization and standardization of pain maps in a diabetic polyneuropathy trial. 

• Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis

  Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.

• Aquatic Invasive Species Control At Hoover Dam

  In this case study, learn why Hoover Dam installed Atlantium's HOD UV treatment system to protect its cooling water systems from Quagga mussels.

• Manufacturing Transfers: Delivering 140+ Precision Medical Devices Without Missing A Deadline

  Go inside a successful manufacturing transfer of over 140 Class-III silicone medical devices and on-time delivery for a top-30 OEM through expert project management and rigorous validation processes.

• RTSM And Clinical Drug Dispensation

  A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

• ICON And Medable Drive 85% eConsent Adoption In U.S. Menopause Study

  A site-focused strategy drove strong eConsent adoption in a complex women’s health study, showing how tailored training and hands-on support boost engagement and compliance.

• EHR-To-EDC Success In A Complex, Adaptive Platform Trial

  I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.

• Optimizing Early-Stage Oncology

  A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.